ACP-104 in Acutely Psychotic Subjects With Schizophrenia

NCT00490516 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: ACP-104
DRUG: ACP-104
DRUG: Placebo

Sponsor

ACADIA Pharmaceuticals Inc.